Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
01/1993
01/27/1993EP0524639A2 Process for the labelling of substances with technetium or rhenium
01/27/1993EP0524584A2 Method for the preparation of high-affinity hapten-specific antibodies and a composition for the detection of haptens
01/27/1993EP0524553A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use
01/27/1993EP0348442B1 Altered antibody
01/27/1993CA2074590A1 Process for the production of high affinity anti-hapten antibodies and composition for the determination of haptens
01/26/1993US5182366 Simplified method of forming identifiable sequences of amino acids
01/26/1993US5182260 Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them
01/26/1993US5182113 Factor xa inibitor from leech and pharmaceutical compositions containing same
01/23/1993WO1993002211A1 Method of stabilizing proteins during optical tests
01/23/1993CA2092098A1 Process for the stabilization of proteins in optical tests
01/21/1993WO1993001484A1 A method to identify protein sequences that fold into a known three-dimensional structure
01/21/1993WO1993001241A1 Use of unpigmented fish skin, particularly from flat fish, as a novel industrial source of collagen, extraction method, and collagen and biomaterial thereby obtained
01/21/1993WO1993001208A1 2-[3-(4-amidinophenyl)]propionic acid derivatives, their preparation and their use
01/21/1993WO1993001207A1 Process for the purification of serum albumin
01/21/1993WO1993001206A1 Conformationally restricted biologically active peptides, methods for their production and uses thereof
01/21/1993WO1993001167A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same
01/21/1993WO1993000923A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor
01/21/1993WO1993000807A1 Method for stabilization of biomaterials
01/21/1993CA2113190A1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor
01/21/1993CA2112580A1 2-substituted 3-(4-amidinophenyl) propionic acid derivatives, the preparation and use thereof
01/20/1993EP0523982A1 Low-viscosity polymer solution for capillary electrophoresis
01/20/1993EP0523461A2 Process for the saponification of aminoacid-/peptide ester
01/20/1993EP0523449A2 Reductive amination of an aminoacid or an aminoacid derivative with an alpha-keto acid or an alpha-keto acid derivative
01/20/1993EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins
01/20/1993EP0523296A1 An improved method for folding tissue plasminogen activators and derivatives thereof
01/19/1993US5180816 Fab fragments, sulfhydryl containing coupler, thioester
01/19/1993US5180815 Modified protein for carrying hapten
01/19/1993US5180811 Proteins having a tnf action comprising tnf-fibromectin fusion protein
01/19/1993US5180807 C-terminal peptide or protein sequencing reagent and method
01/19/1993US5180678 Uses of substantially pure interleukin-9 receptor
01/19/1993US5180668 Hirudin derivative
01/19/1993CA1312995C Method for producing indan derivatives
01/19/1993CA1312994C2 Protein purification
01/19/1993CA1312991C Solid supports for peptide synthesis
01/16/1993CA2073818A1 Transesterification and other conversion reactions of acid derivatives, using an amidine
01/16/1993CA2047063A1 Method for folding tissue plasminogen activators and erivatives thereof
01/14/1993DE4122846A1 Controlling specificity of liq.-solid heterogeneous process - using non-diffusion limited solid matrix, by varying contact time, etc., e.g. for sepn. of albumin from immunoglobulin
01/14/1993DE4121753A1 Purificn. of peptide derivs. by chromatography on hydrophobic carrier - uses acidic eluent so that lipophilic impurities are retained but target cpd. is not and providing high yield at high column loadings
01/13/1993EP0522560A2 Method and composition for the prevention of Lyme disease
01/13/1993EP0522203A1 Protein from lactic acid bacteria
01/13/1993EP0522086A1 DNA SEQUENCE ENCODING GALACTOPROTEIN b3.
01/13/1993EP0522073A1 Improved major histocompatibility complex (mhc) molecules
01/13/1993EP0521996A1 Catalytic antibody components
01/13/1993EP0521911A1 Method and device for moving molecules by the application of a plurality of electrical fields
01/12/1993US5179199 Ion exchanging, washing with an aqueous solvent and elution
01/12/1993US5179197 Removing transferrins and peroxidase from milk or whey by chromatography, desalting, absorption by ion exchange resin, elution
01/12/1993US5178859 Monoclonal antibodies for binding an antigen of Borrelia and epitopes
01/12/1993CA1312702C Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use
01/07/1993WO1993000625A1 Computer-controlled, module type, multipurpose synthesizer
01/07/1993WO1993000365A2 Hepatitis c virus (hcv) polypeptides
01/07/1993WO1993000363A1 Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
01/07/1993WO1993000355A1 Protein sequencing
01/07/1993WO1993000107A1 Therapeutic fragments of von willebrand factor
01/07/1993WO1993000105A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain
01/07/1993WO1993000049A1 Osteogenic factor
01/07/1993EP0521408A1 Glycopeptide antibiotics derivated from balhimycin
01/07/1993EP0483162A4 Sequential c-terminal degradation of peptides and proteins
01/07/1993DE4209215A1 Hcv peptidantigene und verfahren zur bestimmung von hcv HCV peptide antigens, and methods for the determination of HCV
01/07/1993DE4121947A1 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung 2- (3- (4-amidino-phenyl)) - propionic acid derivatives, their preparation and use
01/07/1993CA2112226A1 Purification of recombinant apolipoprotein e from bacteria
01/07/1993CA2111870A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain
01/07/1993CA2093790A1 Osteogenic factor
01/06/1993CN1067680A Hepatitis b virus surface proteins with reduced host carbohydrate content
01/05/1993WO1993001210A2 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv)
01/05/1993US5177194 Process for purifying immune serum globulins
01/05/1993CA2089576A1 Hcv peptide antigens and methods for the determination of hcv
01/02/1993CA2072824A1 Cluster conjugates of drugs with antibodies
12/1992
12/30/1992EP0520748A1 Storage of materials
12/30/1992EP0520573A1 Cyclic imide derivatives
12/30/1992EP0520502A2 Anti-Hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
12/30/1992EP0519986A1 Synthetic polypeptides
12/30/1992EP0519953A1 Acyl phosphate esters and modification of proteins therewith.
12/30/1992EP0208785B1 Fibrinophilic urokinase complex and process for its preparation
12/30/1992CA2072725A1 Glycopeptides, a process for their preparation and their use
12/29/1992US5175254 Solid phase peptide synthesis using a polyacrylic support in aqueous solution
12/29/1992US5175146 Synthetic calcitonin peptides
12/29/1992US5175105 Process for the production of urokinase using saccharomyes cerevisiae
12/29/1992US5175096 Dna encoding a fibronectin binding protein as well as its preparation
12/28/1992CA2072551A1 Cyclic imide derivatives
12/23/1992WO1992022875A1 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA)
12/23/1992WO1992022646A1 Production of human hemoglobin in transgenic pigs
12/23/1992WO1992022644A1 Production of a protein of interest in the milk of a transgenic mammelian
12/23/1992WO1992022591A1 Polymeric resin for peptide synthesis
12/23/1992WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins
12/23/1992WO1992022569A1 Peptides with tachykinin antagonist activity
12/23/1992WO1992022566A1 Protected amino-acid unit, its preparation and its use
12/23/1992WO1992022324A1 Microbially-produced antibody fragments and their conjugates
12/23/1992WO1992022319A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-β1 BINDING MOLECULES AND USES THEREOF
12/23/1992WO1992022318A1 Amino acid derivative and bromoacetyl modified peptides
12/23/1992WO1992015605A3 Inhibitors of human neutrophil elastase and human cathepsin g
12/23/1992EP0519903A1 Drug containing activated protein C
12/23/1992EP0519889A2 Leydig cell stimulator
12/23/1992EP0519726A2 A process for large-scale production of antimicrobial peptide in high purity
12/23/1992EP0519640A1 Rapid synthesis and screening of peptide mimetics
12/23/1992EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides
12/23/1992EP0519327A1 N-Acyl-S-(2-hydroxyalkyl)-cysteines, their preparation and their use as intermediates in the preparation of synthetic immunoadjuvants and synthetic vaccines
12/23/1992EP0519203A2 Apparatus and method for electrophoretic separation of proteins
12/23/1992EP0519039A1 HUMAN bFGF DERIVATIVES, THEIR ANALOGS AND PROCESS FOR THEIR PRODUCTION
12/23/1992EP0519001A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/23/1992EP0518982A1 Method for enhancing antibody transport through capillary barriers